English українська
  1. SumDU Repository

Browsing by Author Zhou, C.


Showing results 1 to 3 of 3
Issue Year Title Author(s) Type Views Downloads
2022 Atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: Sub-analysis from the pivotal phase III IMpower010 study Felip, E.; Altorki, N.K.; Zhou, C.; Vallieres, E.; Vynnychenko, Ihor Oleksandrovych; Akopov, A.; Martinez-Marti, A.; Chella, A.; Bondarenko, I.; Ursol, G.; Levchenko, E.; Kislov, N.; Liersch, R.; Belleli, R.; McNally, V.A.; Bennett, E.; Gitlitz, B.J.; Wakelee, H. Conference Papers 4009127 5569260
2023 KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC Ren, S.; Feng, J.; Ma, S.; Chen, H.; Ma, Z.; Huang, C.; Zhang, L.; He, J.; Wang, C.; Zhou, J.; Danchaivijitr, P.; Wang, C.-C.; Vynnychenko, Ihor Oleksandrovych; Wang, K.; Orlandi, F.; Sriuranpong, V.; Li, B.; Ge, J.; Dang, T.; Zhou, C. Article 726 71
2020 Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033 Zhou, C.; Feng, S.; Ma, S.; Chen, H.; Ma, Z.; Huang, C.; Zhang, L.; He, J.; Wang, C.; Zhou, J.; Danchaivijtr, P.; Huang, H-C.; Vynnychenko, Ihor Oleksandrovych; Wang, K.; Orlandi, F.; Sriuranpong, V.; Li, B.; Ge, J.; Dang, T. Conference Papers 1963732892 112788198